ストックスクリーナーアプリを入手
0.63
3.45%
0.021
アフターアワーズ：
.63
前日終値:
$0.609
開ける：
$0.61
24時間の取引高:
62,594
Relative Volume:
0.79
時価総額：
$39.57M
収益：
$37.06M
当期純損益:
$-8.20M
株価収益率:
-4.7262
EPS:
-0.1333
ネットキャッシュフロー:
$-12.87M
1週間 パフォーマンス:
+1.60%
1か月 パフォーマンス:
+3.28%
6か月 パフォーマンス:
-9.73%
1年 パフォーマンス:
-27.67%
1日の値動き範囲:
$0.61
$0.63
1週間の範囲:
$0.5685
$0.63
52週間の値動き範囲:
$0.4992
$1.39
Cytosorbents Corp Stock (CTSO) Company Profile
Compare CTSO vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.63 | 38.25M | 37.06M | -8.20M | -12.87M | -0.1333 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2020-09-17 | 開始されました | Jefferies | Buy |
| 2020-09-01 | 開始されました | SVB Leerink | Outperform |
| 2017-08-08 | 繰り返されました | Maxim Group | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-05-24 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 繰り返されました | MLV & Co | Buy |
| 2015-04-01 | 繰り返されました | MLV & Co | Buy |
| 2015-03-05 | 開始されました | MLV & Co | Buy |
| 2015-02-25 | 開始されました | WBB Securities | Speculative Buy |
| 2015-01-27 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Cytosorbents Corp (CTSO) 最新ニュース
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 - Quantisnow
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights - BioSpace
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Aktiellt
CTSO Analyst Rating Update: HC Wainwright Lowers Price Target | - GuruFocus
Executive Compensation, Stock Options, and Corporate Governance Disclosure - Minichart
Governance, pay and ownership detailed in CytoSorbents (NASDAQ: CTSO) 10-K/A - Stock Titan
CTSO (Cytosorbents Corporation) posts 4.1 percent Q4 2025 revenue growth as shares edge higher despite a wide EPS miss.Stock Idea Sharing Hub - newser.com
CytoSorbents implemented workforce and cost reduction program - TipRanks
Cytosorbents granted 180-day extension by Nasdaq to meet minimum bid price - Investing.com South Africa
CytoSorbents Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Nasdaq gives CytoSorbents (NASDAQ: CTSO) more time on $1 bid rule - Stock Titan
Cytosorbents (CTSO) Takes Regulatory Gamble While Insiders Remain on the Sidelines and Institutions Are Divided - Bitget
CytoSorbents Corp (HQE1.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
CytoSorbents Corp (HQE1.MU) stock price, news, quote and history - Yahoo Finance UK
CytoSorbents Corporation 2025 Annual Report: Blood Purification Technologies, Clinical Trials, and Regulatory Insights - Minichart
Cytosorbents 10-K: Revenue $37.1M, EPS not disclosed - TradingView
CytoSorbents (NASDAQ: CTSO) outlines global blood purification push and FDA path - Stock Titan
Cytosorbents’ Earnings Call Balances Progress and Risk - The Globe and Mail
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2025 Earnings Call Transcript - Insider Monkey
Cytosorbents (CTSO) Q4 2025 Earnings Transcript - AOL.com
CytoSorbents 2025 Financials: Q4 & Annual Revenue and Loss ReportNews and Statistics - IndexBox
Cytosorbents Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
H.C. Wainwright reiterates CytoSorbents stock rating at Neutral By Investing.com - Investing.com Canada
H.C. Wainwright reiterates CytoSorbents stock rating at Neutral - Investing.com
CytoSorbents Reports 2025 Financial Results: Revenue Growth, Clinical Advances, and Path to Cash Flow Breakeven in 2026 - Minichart
CytoSorbents (CTSO) Reports Slight Revenue Increase and Strategi - GuruFocus
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... By GuruFocus - Investing.com Canada
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory Challenges - GuruFocus
Earnings call transcript: CytoSorbents reports Q4 2025 earnings miss, shares dip - Investing.com Australia
Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cytosorbents (CTSO) Reports Record Sales Growth in 2025 - GuruFocus
CytoSorbents Corp (NASDAQ:CTSO) Reports Q4 2025 Earnings Miss, Stock Declines - chartmill.com
CytoSorbents: Q4 Earnings Snapshot - Barchart.com
CYTOSORBENTS ($CTSO) Releases Q4 2025 Earnings - Quiver Quantitative
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cytosorbents (CTSO) Expected to Announce Earnings on Monday - Defense World
If You Invested $1,000 in Cytosorbents Corp (CTSO) - Stock Titan
Aug Drivers: How does Cytosorbents Corporation score in quality rankingsMarket Growth Summary & Safe Capital Growth Plans - baoquankhu1.vn
CytoSorbents Corp Stock (ISIN: US23283M1018) Faces Analyst Hold Amid Massive Upside Potential - AD HOC NEWS
Cytosorbents CorporationCommon Stock (Nasdaq:CTSO) Stock Quote - The Chronicle-Journal
CytoSorbents (CTSO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
CTSO PE Ratio & Valuation, Is CTSO Overvalued - Intellectia AI
Aug Fed Impact: Will Cytosorbents Corporation benefit from government policy2025 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - BioSpace
CTSO SEC FilingsCytosorbents Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Latest CTSO NewsCytoSorbents Announces the REFRESH 2-AKI Tr... - Stock Titan
CTSO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CTSO.O PE Ratio & Valuation, Is CTSO.O Overvalued - Intellectia AI
Travel Stocks: What makes Cytosorbents Corporation stock attractive today2025 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
Head to Head: Cytosorbents vs. Futureworld - National Today
Cytosorbents Corp (CTSO) 財務データ
収益
当期純利益
現金流量
EPS
3.34%
大文字化:
|
ボリューム (24 時間):